Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

Rang in aandelen #447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Aandeelprijs
$764.04
Marktkapitalisatie
$53.36B
Verandering (1 dag)
0.96%
Verandering (1 jaar)
8.59%
Land
CH
Handel Lonza Group AG (LONN)

Categorie

Healthcare
Aandelsplitsingen voor Lonza Group AG (LONN)
Het aandeel Lonza Group AG (symbool: LONN) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 22, 2026.
Eén aandeel LONN dat vóór Oct 22, 2026 werd gekocht, staat nu gelijk aan 0 aandelen LONN.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 1 x100
BE